Cover
Cover - shares | 9 Months Ended | |
Sep. 30, 2022 | Nov. 10, 2022 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Document Period End Date | Sep. 30, 2022 | |
Document Fiscal Period Focus | Q3 | |
Document Fiscal Year Focus | 2022 | |
Current Fiscal Year End Date | --12-31 | |
Entity File Number | 333-168895 | |
Entity Registrant Name | QUEST WATER GLOBAL, INC. | |
Entity Central Index Key | 0001487091 | |
Entity Tax Identification Number | 27-1994359 | |
Entity Incorporation, State or Country Code | DE | |
Entity Address, Address Line One | Suite 209 – 828 Harbourside Drive | |
Entity Address, City or Town | North Vancouver | |
Entity Address, State or Province | BC | |
Entity Address, Country | CA | |
Entity Address, Postal Zip Code | V7P 3R9 | |
City Area Code | 888 | |
Local Phone Number | 897-5536 | |
Entity Current Reporting Status | No | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 131,903,029 |
Condensed Consolidated Interim
Condensed Consolidated Interim Balance Sheets (Unaudited) - USD ($) | Sep. 30, 2022 | Dec. 31, 2021 |
Current assets | ||
Cash | $ 54 | $ 4,227 |
Prepaids | 4,453 | |
Total current assets | 4,507 | 4,227 |
Equipment, net (Note 4) | 1,292 | |
Investment (Note 3) | 7,220 | 7,220 |
Total assets | 13,019 | 11,447 |
Current liabilities | ||
Accounts payable and accrued liabilities | 27,843 | 15,100 |
Due to related company (Note 3) | 12,606 | 33,964 |
Due to related parties (Note 5) | 1,030,496 | 3,632,758 |
Total liabilities | 1,070,945 | 3,681,822 |
Stockholders’ deficit | ||
Preferred stock, 5,000,000 shares authorized, $0.000001 par value 2 shares issued and outstanding | 1 | 1 |
Common stock, 500,000,000 shares authorized, $0.000001 par value 131,903,029 issued and outstanding | 132 | 85 |
Additional paid-in capital | 10,171,803 | 6,332,748 |
Deficit | (11,229,862) | (10,003,209) |
Total stockholders’ deficit | (1,057,926) | (3,670,375) |
Total liabilities and stockholders’ deficit | $ 13,019 | $ 11,447 |
Condensed Consolidated Interi_2
Condensed Consolidated Interim Balance Sheets (Unaudited) (Parenthetical) - $ / shares | Sep. 30, 2022 | Dec. 31, 2021 |
Statement of Financial Position [Abstract] | ||
Preferred stock, shares authorized | 5,000,000 | 5,000,000 |
Preferred stock, par value | $ 0.000001 | $ 0.000001 |
Preferred stock, shares issued | 2 | 2 |
Preferred stock, shares outstanding | 2 | 2 |
Common stock, shares authorized | 500,000,000 | 500,000,000 |
Common stock, par value | $ 0.000001 | $ 0.000001 |
Common stock, shares issued | 131,903,029 | 131,903,029 |
Common stock, shares outstanding | 131,903,029 | 131,903,029 |
Condensed Consolidated Interi_3
Condensed Consolidated Interim Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Income Statement [Abstract] | ||||
Sales | $ 790 | $ 150,790 | ||
Cost of goods sold | 1,050 | 113,774 | ||
Gross profit | (260) | 37,016 | ||
Expenses | ||||
Automotive | 2,417 | 2,307 | 7,732 | 7,111 |
Consulting fees | 771 | 771 | ||
Management fees | 112,500 | 107,500 | 337,500 | 322,500 |
Office and miscellaneous | 5 | (880) | 3,256 | 3,342 |
Professional fees | 12,921 | 8,884 | 40,078 | 9,271 |
Rent | 5,470 | 5,250 | 16,259 | 15,750 |
Telephone | 762 | 712 | 2,602 | 2,350 |
Transfer agent and filing fees | 4,120 | 6,487 | 18,124 | 7,119 |
Stock based compensation | 801,102 | 801,102 | ||
Total expenses | 939,297 | 131,031 | 1,226,653 | 368,214 |
Net loss and comprehensive loss | $ (939,297) | $ (131,291) | $ (1,226,653) | $ (331,198) |
Net loss per share, basic and diluted | $ (0.008) | $ (0.002) | $ (0.012) | $ (0.004) |
Weighted average number of shares outstanding, basic and diluted | 120,726,441 | 85,164,569 | 97,148,790 | 85,164,569 |
Condensed Consolidated Interi_4
Condensed Consolidated Interim Statements of Stockholder's Deficit (Unaudited) - USD ($) | Preferred Stock [Member] | Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Total |
Beginning balance, value at Dec. 31, 2020 | $ 1 | $ 85 | $ 6,332,748 | $ (9,741,165) | $ (3,408,331) |
Beginning balance, shares at Dec. 31, 2020 | 2 | 85,164,569 | |||
Net loss for the period | (82,553) | (82,553) | |||
Ending balance, value at Mar. 31, 2021 | $ 1 | $ 85 | 6,332,748 | (9,823,718) | (3,490,884) |
Ending balance, shares at Mar. 31, 2021 | 2 | 85,164,569 | |||
Beginning balance, value at Dec. 31, 2020 | $ 1 | $ 85 | 6,332,748 | (9,741,165) | (3,408,331) |
Beginning balance, shares at Dec. 31, 2020 | 2 | 85,164,569 | |||
Net loss for the period | (331,198) | ||||
Shares issued for debt | |||||
Stock based compensation | |||||
Ending balance, value at Sep. 30, 2021 | $ 1 | $ 85 | 6,332,748 | (10,072,363) | (3,739,529) |
Ending balance, shares at Sep. 30, 2021 | 2 | 85,164,569 | |||
Beginning balance, value at Mar. 31, 2021 | $ 1 | $ 85 | 6,332,748 | (9,823,718) | (3,490,884) |
Beginning balance, shares at Mar. 31, 2021 | 2 | 85,164,569 | |||
Net loss for the period | (117,354) | (117,354) | |||
Ending balance, value at Jun. 30, 2021 | $ 1 | $ 85 | 6,332,748 | (9,941,072) | (3,608,238) |
Ending balance, shares at Jun. 30, 2021 | 2 | 85,164,569 | |||
Net loss for the period | (131,291) | (131,291) | |||
Stock based compensation | |||||
Ending balance, value at Sep. 30, 2021 | $ 1 | $ 85 | 6,332,748 | (10,072,363) | (3,739,529) |
Ending balance, shares at Sep. 30, 2021 | 2 | 85,164,569 | |||
Beginning balance, value at Dec. 31, 2021 | $ 1 | $ 85 | 6,332,748 | (10,003,209) | (3,670,375) |
Beginning balance, shares at Dec. 31, 2021 | 2 | 85,164,569 | |||
Net loss for the period | (144,635) | (144,635) | |||
Ending balance, value at Mar. 31, 2022 | $ 1 | $ 85 | 6,332,748 | (10,147,844) | (3,815,010) |
Ending balance, shares at Mar. 31, 2022 | 2 | 85,164,569 | |||
Beginning balance, value at Dec. 31, 2021 | $ 1 | $ 85 | 6,332,748 | (10,003,209) | (3,670,375) |
Beginning balance, shares at Dec. 31, 2021 | 2 | 85,164,569 | |||
Net loss for the period | (1,226,653) | ||||
Shares issued for debt | (3,038,000) | ||||
Stock based compensation | 801,102 | ||||
Ending balance, value at Sep. 30, 2022 | $ 1 | $ 132 | 10,171,803 | (11,229,862) | (1,057,926) |
Ending balance, shares at Sep. 30, 2022 | 2 | 131,903,029 | |||
Beginning balance, value at Mar. 31, 2022 | $ 1 | $ 85 | 6,332,748 | (10,147,844) | (3,815,010) |
Beginning balance, shares at Mar. 31, 2022 | 2 | 85,164,569 | |||
Net loss for the period | (142,721) | (142,721) | |||
Ending balance, value at Jun. 30, 2022 | $ 1 | $ 85 | 6,332,748 | (10,290,565) | (3,957,731) |
Ending balance, shares at Jun. 30, 2022 | 2 | 85,164,569 | |||
Net loss for the period | (939,297) | (939,297) | |||
Shares issued for debt | $ 47 | 3,037,953 | 3,038,000 | ||
Shares issued for debt, shares | 43,738,460 | ||||
Stock based compensation | 801,102 | 801,102 | |||
Ending balance, value at Sep. 30, 2022 | $ 1 | $ 132 | $ 10,171,803 | $ (11,229,862) | $ (1,057,926) |
Ending balance, shares at Sep. 30, 2022 | 2 | 131,903,029 |
Condensed Consolidated Interi_5
Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($) | 3 Months Ended | 9 Months Ended | |
Sep. 30, 2022 | Sep. 30, 2022 | Sep. 30, 2021 | |
Operating Activities: | |||
Net loss for the period | $ (939,297) | $ (1,226,653) | $ (331,198) |
Depreciation | 208 | ||
Shares issued for debt | (3,038,000) | 3,038,000 | |
Stock based compensation | 801,102 | 801,102 | |
Changes in operating assets and liabilities: | |||
Prepaids | (4,453) | (7,541) | |
Unbilled costs | 112,724 | ||
Accounts payable and accrued liabilities | 12,743 | (14,165) | |
Due to related company | (21,358) | (150,000) | |
Due to related parties | (2,602,262) | 389,749 | |
Net cash used in operating activities | (2,673) | (431) | |
Cash flows from investing activities: | |||
Equipment purchases | (1,500) | ||
Net cash used in investing activities | (1,500) | ||
Change in cash | (4,173) | (431) | |
Cash, beginning of period | 4,227 | 4,715 | |
Cash, end of period | $ 54 | 54 | 4,284 |
Supplemental disclosures: | |||
Interest paid | |||
Income tax paid |
Nature of Operations and Contin
Nature of Operations and Continuance of Business | 9 Months Ended |
Sep. 30, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Nature of Operations and Continuance of Business | 1. Nature of Operations and Continuance of Business Quest Water Global, Inc. (the “Company”) was incorporated on February 25, 2010, under the laws of the State of Delaware. The Company is an innovative water technology company that provides solutions to water scarce regions. The Company’s operations to date have been limited primarily to capital formation, organization, and development of its business plan. On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic. This contagious disease outbreak and any related adverse public health developments, has adversely affected workforces, economies, and financial markets globally, leading to an economic downturn. The impact on the Company has not been significant, but management continues to monitor the situation. These consolidated interim financial statements have been prepared on a going concern basis, which implies the Company will continue to realize its assets and discharge its liabilities in the normal course of business. As at September 30, 2022, the Company has a working capital deficiency of $ 1,066,438 1,030,496 11,229,862 |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 9 Months Ended |
Sep. 30, 2022 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | 2. Summary of Significant Accounting Policies (a) Basis of Presentation and Principles of Consolidation These consolidated interim financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States (“US GAAP”) and are expressed in US dollars. These consolidated financial statements include the accounts of the Company; the Company’s wholly-owned subsidiary Quest Water Solutions, Inc., a company incorporated under the laws of the State of Nevada (“Quest Nevada”); AQUAtap Global, Inc., a company incorporated under the laws of the State of Wyoming; and Quest Nevada’s wholly-owned subsidiary, Quest Water Solutions Inc., a company incorporated under the laws of the Province of British Columbia, Canada. All inter-company balances and transactions have been eliminated on consolidation. (b) Interim Financial Statements The accompanying condensed consolidated interim financial statements of the Company should be read in conjunction with the consolidated financial statements and accompanying notes for the fiscal year ended December 31, 2021. In the opinion of management, the accompanying condensed consolidated interim financial statements reflect all adjustments of a recurring nature considered necessary to present fairly the Company’s financial position and the results of its operations and its cash flows for the periods shown. The preparation of these condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ materially from those estimates. The results of operations and cash flows for the periods shown are not necessarily indicative of the results to be expected for the full year. (c) Foreign Currency Translation The Company’s functional currency is US dollars. Transactions in foreign currencies are translated into the currency of measurement at the exchange rates in effect on the transaction date. Monetary balance sheet items expressed in foreign currencies are translated into US dollars at the exchange rates in effect at the balance sheet date. The resulting exchange gains and losses are recognized in income. The Company’s integrated foreign subsidiaries are financially or operationally dependent on the Company. The Company uses the temporal method to translate the accounts of its integrated operations into US dollars. Monetary assets and liabilities are translated at the exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are translated at historical rates. Revenues and expenses are translated at average rates for the period, except for amortization, which is translated on the same basis as the related asset. The resulting exchange gains or losses are recognized in income. (d) Recent Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations. |
Investment in and Due to Relate
Investment in and Due to Related Company | 9 Months Ended |
Sep. 30, 2022 | |
Investments, All Other Investments [Abstract] | |
Investment in and Due to Related Company | 3. Investment in and Due to Related Company During the year ended December 31, 2019, the Company invested $ 7,600 38 no As at December 31, 2020, AQUAtap had advanced $ 183,964 150,000 During the year ended December 31, 2021, the sale was completed and the Company recorded the prepayment as a sale. Accordingly, as at December 31, 2021, the account was reduced by $ 150,000 33,964 |
Equipment
Equipment | 9 Months Ended |
Sep. 30, 2022 | |
Property, Plant and Equipment [Abstract] | |
Equipment | 4. Equipment Equipment is amortized over its useful life. Schedule of Property and Equipment Cost Depreciation Net Computer 3 years $ 1,500 $ 208 $ 1,292 |
Related Party Transactions
Related Party Transactions | 9 Months Ended |
Sep. 30, 2022 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | 5. Related Party Transactions (a) As at September 30, 2022, a total of $ 431,638 1,703,755 (b) As at September 30, 2022, a total of $ 598,858 1,929,003 (c) For the nine months ended September 30, 2022, the Company incurred a total of $ 337,500 322,500 (d) For the nine months ended September 30, 2022, the Company incurred $ 15,750 15,750 (e) On July 22, 2022, the Company issued 46,738,460 0.065 3,038,000 |
Common Stock
Common Stock | 9 Months Ended |
Sep. 30, 2022 | |
Equity [Abstract] | |
Common Stock | 6. Common Stock On July 21, 2022, the authorized capital of the Company was increased from 95,000,000 500,000,000 0.000001 On July 22, 2022, the Company converted an aggregate of $ 3,038,000 46,738,460 0.065 At September 30, 2022, the Company had 131,903,029 85,164,569 Basic and diluted loss per share The calculation of the basic and diluted loss per share for the nine months ended September 30, 2022 was based on the loss attributable to common shareholders of $ 454,684 331,198 97,148,790 85,164,569 At September 30, 2022, 8,500,000 |
Share Based Payments
Share Based Payments | 9 Months Ended |
Sep. 30, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Share Based Payments | 7. Share Based Payments Stock Options The Company adopted a stock option plan in May 2012 (the “Plan”) under which it is authorized to grant options to directors, officers, employees and consultants enabling them to acquire up to a maximum of 10 10 Stock option transactions are summarized as follows: Summary of Stock Option Activity Number of Weighted Average Options Exercise Price Balance, December 31, 2021 - $ - Granted 8,500,000 0.10 Exercised - - Cancelled/Expired - - Balance, September 30, 2022 8,500,000 $ 0.10 Exercisable at September 30, 2022 7,700,000 $ 0.10 The options outstanding and exercisable at September 30, 2022 have an exercise price of $ 0.10 4.79 800,000 0.10 For the nine months ended September 30, 2022, the Company recognized stock based payment expense of $ 801,102 |
Correction of Previously Issued
Correction of Previously Issued Financial Statements | 9 Months Ended |
Sep. 30, 2022 | |
Accounting Changes and Error Corrections [Abstract] | |
Correction of Previously Issued Financial Statements | 8. Correction of Previously Issued Financial Statements During the year ended December 31, 2014, the Company entered into consulting and marketing agreements whereby it committed to issue 500,000 40,025 The following changes reflect the adjustment of $ 40,025 Consolidated Statement of Stockholders’ Deficit Schedule of Stockholders’ Deficit Common stock Deficit Total $ $ $ Balance, December 31, 2020, as previously stated 40,025 (9,781,190 ) (3,408,331 ) Adjustment (40,025 ) 40,025 – Balance, December 31, 2020, as restated – (9,741,165 ) (3,408,331 ) |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 9 Months Ended |
Sep. 30, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation and Principles of Consolidation | (a) Basis of Presentation and Principles of Consolidation These consolidated interim financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States (“US GAAP”) and are expressed in US dollars. These consolidated financial statements include the accounts of the Company; the Company’s wholly-owned subsidiary Quest Water Solutions, Inc., a company incorporated under the laws of the State of Nevada (“Quest Nevada”); AQUAtap Global, Inc., a company incorporated under the laws of the State of Wyoming; and Quest Nevada’s wholly-owned subsidiary, Quest Water Solutions Inc., a company incorporated under the laws of the Province of British Columbia, Canada. All inter-company balances and transactions have been eliminated on consolidation. |
Interim Financial Statements | (b) Interim Financial Statements The accompanying condensed consolidated interim financial statements of the Company should be read in conjunction with the consolidated financial statements and accompanying notes for the fiscal year ended December 31, 2021. In the opinion of management, the accompanying condensed consolidated interim financial statements reflect all adjustments of a recurring nature considered necessary to present fairly the Company’s financial position and the results of its operations and its cash flows for the periods shown. The preparation of these condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ materially from those estimates. The results of operations and cash flows for the periods shown are not necessarily indicative of the results to be expected for the full year. |
Foreign Currency Translation | (c) Foreign Currency Translation The Company’s functional currency is US dollars. Transactions in foreign currencies are translated into the currency of measurement at the exchange rates in effect on the transaction date. Monetary balance sheet items expressed in foreign currencies are translated into US dollars at the exchange rates in effect at the balance sheet date. The resulting exchange gains and losses are recognized in income. The Company’s integrated foreign subsidiaries are financially or operationally dependent on the Company. The Company uses the temporal method to translate the accounts of its integrated operations into US dollars. Monetary assets and liabilities are translated at the exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are translated at historical rates. Revenues and expenses are translated at average rates for the period, except for amortization, which is translated on the same basis as the related asset. The resulting exchange gains or losses are recognized in income. |
Recent Accounting Pronouncements | (d) Recent Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations. |
Equipment (Tables)
Equipment (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Property, Plant and Equipment [Abstract] | |
Schedule of Property and Equipment | Equipment is amortized over its useful life. Schedule of Property and Equipment Cost Depreciation Net Computer 3 years $ 1,500 $ 208 $ 1,292 |
Share Based Payments (Tables)
Share Based Payments (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Summary of Stock Option Activity | Stock option transactions are summarized as follows: Summary of Stock Option Activity Number of Weighted Average Options Exercise Price Balance, December 31, 2021 - $ - Granted 8,500,000 0.10 Exercised - - Cancelled/Expired - - Balance, September 30, 2022 8,500,000 $ 0.10 Exercisable at September 30, 2022 7,700,000 $ 0.10 |
Correction of Previously Issu_2
Correction of Previously Issued Financial Statements (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Accounting Changes and Error Corrections [Abstract] | |
Schedule of Stockholders’ Deficit | Consolidated Statement of Stockholders’ Deficit Schedule of Stockholders’ Deficit Common stock Deficit Total $ $ $ Balance, December 31, 2020, as previously stated 40,025 (9,781,190 ) (3,408,331 ) Adjustment (40,025 ) 40,025 – Balance, December 31, 2020, as restated – (9,741,165 ) (3,408,331 ) |
Nature of Operations and Cont_2
Nature of Operations and Continuance of Business (Details Narrative) - USD ($) | Sep. 30, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||
Working capital deficiency | $ 1,066,438 | ||
Liability of principal stockholders | 1,030,496 | ||
Accumulated deficit | $ 11,229,862 | $ 10,003,209 | $ 9,741,165 |
Investment in and Due to Rela_2
Investment in and Due to Related Company (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Due to related parties | $ 12,606 | $ 12,606 | $ 33,964 | ||||
Revenue | $ 790 | $ 150,790 | |||||
AQUAtap [Member] | |||||||
Equity method investment, ownership percentage | 38% | ||||||
AQUAtap [Member] | |||||||
Investments | $ 7,600 | ||||||
Gain loss on investment | $ 0 | 0 | $ 0 | ||||
Due to related parties | 33,964 | 183,964 | |||||
Prepayment from purchaser | $ 150,000 | ||||||
Revenue | $ 150,000 |
Schedule of Property and Equipm
Schedule of Property and Equipment (Details) - USD ($) | 9 Months Ended | |
Sep. 30, 2022 | Dec. 31, 2021 | |
Property, Plant and Equipment [Line Items] | ||
Equipment, cost | $ 1,500 | |
Equipment, depreciation | 208 | |
Equipment, net | $ 1,292 | |
Computer Equipment [Member] | ||
Property, Plant and Equipment [Line Items] | ||
Equipment, Useful Life | 3 years |
Related Party Transactions (Det
Related Party Transactions (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | ||||
Jul. 22, 2022 | Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Dec. 31, 2021 | |
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | ||||||
Due to related parties | $ 1,030,496 | $ 1,030,496 | $ 3,632,758 | |||
Management fee | 112,500 | $ 107,500 | 337,500 | $ 322,500 | ||
Shares issued, price per share | $ 0.065 | |||||
President [Member] | ||||||
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | ||||||
Due to related parties | 431,638 | 431,638 | 1,703,755 | |||
Vice President [Member] | ||||||
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | ||||||
Due to related parties | $ 598,858 | 598,858 | $ 1,929,003 | |||
Payment of rent | 15,750 | 15,750 | ||||
Issuance of shares during period | 46,738,460 | |||||
Issuance of value during period | $ 3,038,000 | |||||
President and Vice President [Member] | ||||||
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] | ||||||
Management fee | $ 337,500 | $ 322,500 |
Common Stock (Details Narrative
Common Stock (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | ||||||
Jul. 22, 2022 | Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Jul. 21, 2022 | Jul. 20, 2022 | Dec. 31, 2021 | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||||||
Authorized share of common stock | 500,000,000 | 500,000,000 | 500,000,000 | 95,000,000 | 500,000,000 | |||
Common stock, par value | $ 0.000001 | $ 0.000001 | $ 0.000001 | $ 0.000001 | ||||
Shares issued, price per share | $ 0.065 | |||||||
Common stock, shares outstanding | 131,903,029 | 131,903,029 | 131,903,029 | |||||
Net income (loss) available to common stockholders, basic | $ 454,684 | $ 331,198 | ||||||
Weighted average number of shares outstanding, basic | 120,726,441 | 85,164,569 | 97,148,790 | 85,164,569 | ||||
Stock option, shares | 8,500,000 | |||||||
Common Stock [Member] | ||||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||||||
Common stock, shares outstanding | 131,903,029 | 131,903,029 | 85,164,569 | |||||
Vice President [Member] | ||||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||||||
Converted of aggregated debt, value | $ 3,038,000 | |||||||
Issuance of shares during period | 46,738,460 |
Summary of Stock Option Activit
Summary of Stock Option Activity (Details) | 9 Months Ended |
Sep. 30, 2022 $ / shares shares | |
Share-Based Payment Arrangement [Abstract] | |
Number of options outstanding, beginning balance | shares | |
Weighted average exercise price, beginning | $ / shares | |
Number of options outstanding, granted | shares | 8,500,000 |
Weighted average exercise price, granted | $ / shares | $ 0.10 |
Number of options outstanding, exercised | shares | |
Weighted average exercise price, exercised | $ / shares | |
Number of options outstanding, cancelled/expired | shares | |
Weighted average exercise price, cancelled/expired | $ / shares | |
Number of options outstanding, ending balance | shares | 8,500,000 |
Weighted average exercise price, Ending | $ / shares | $ 0.10 |
Number of options exercisable | shares | 7,700,000 |
Weighted average exercise price, exercisable | $ / shares | $ 0.10 |
Share Based Payments (Details N
Share Based Payments (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Share-Based Payment Arrangement [Abstract] | ||||
Issued and outstanding common stock percentage | 10% | |||
Option granted maximum term years | 10 years | |||
Exercise price | $ 0.10 | $ 0.10 | ||
Remaining life | 4 years 9 months 14 days | |||
Options, shares | 800,000 | 800,000 | ||
Stock based payment expense | $ 801,102 | $ 801,102 |
Schedule of Stockholders_ Defic
Schedule of Stockholders’ Deficit (Details) - USD ($) | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Sep. 30, 2021 | Jun. 30, 2021 | Mar. 31, 2021 | Dec. 31, 2020 |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
Common stock issuable | ||||||||
Deficit | $ (11,229,862) | $ (10,003,209) | (9,741,165) | |||||
Total Stockholder's Deficit | $ (1,057,926) | $ (3,957,731) | $ (3,815,010) | $ (3,670,375) | $ (3,739,529) | $ (3,608,238) | $ (3,490,884) | (3,408,331) |
Previously Reported [Member] | ||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
Common stock issuable | 40,025 | |||||||
Deficit | (9,781,190) | |||||||
Total Stockholder's Deficit | (3,408,331) | |||||||
Revision of Prior Period, Adjustment [Member] | ||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
Common stock issuable | (40,025) | |||||||
Deficit | 40,025 | |||||||
Total Stockholder's Deficit |
Correction of Previously Issu_3
Correction of Previously Issued Financial Statements (Details Narrative) - USD ($) | 12 Months Ended | |
Dec. 31, 2020 | Dec. 31, 2014 | |
Revision of Prior Period, Adjustment [Member] | ||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
Adjustment to equity | $ 40,025 | |
Consulting and Marketing Agreements [Member] | ||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||
Common stock shares issued | 500,000 | |
Common stock value issued | $ 40,025 |